Exclusive: Thoma Bravo Weighs Multi-Billion Dollar Sale of Healthcare Cybersecurity Leader Imprivata
Private equity giant Thoma Bravo is exploring a sale of Imprivata, a key player in healthcare digital identity software, in a deal that could value the company at up to $7 billion, sources tell Reuters.